Blog

The James Group Newsletter Vol. 4, Num. 15: Lawsuit Linking Baby Powder & Cancer, EpiPen Settlement Finalized, New UHC CEO, Bubonic Plague in AZ, Young People Dying of Colon Cancer, Shop Around for Health Costs, Anthem Exits CA, TN Promotes ACA Enrollment

 

Logo R

 

        Solutions R

 

August 22, 2017 

Volume 4, Number 15

In This Issue

Lawsuit Linking Baby Powder to Cancer

EpiPen Settlement Finalized

New UHC CEO

Bubonic Plague in AZ

Young People Dying of Colon Cancer

Anthem Exits CA

TN Promotes ACA Enrollment

TJG On Facebook

Contact Us

The James Group, LLC

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memphis:  901-273-8600

Atlanta:      770-709-7210

This Newsletter is provided for informational purposes only. It is not intended as legal or tax advice nor does it create an attorney/client relationship between The James Group, LLC and any readers or recipients. Readers should consult counsel of their own choosing to discuss how these matters relate to their individual circumstances. Reproduction in whole or in part is prohibited without the express written consent of The James Group, LLC.

To Unsubscribe, please reply with UNSUSCRIBE in the Subject line.

The Associated Press: Record $417M Award In Lawsuit Linking Baby Powder To Cancer The verdict in the lawsuit brought by the California woman, Eva Echeverria, marks the largest sum awarded in a series of talcum powder lawsuit verdicts against Johnson & Johnson in courts around the U.S. Echeverria alleged Johnson & Johnson failed to adequately warn consumers about talcum powder’s potential cancer risks. She used the company’s baby powder on a daily basis beginning in the 1950s until 2016 and was diagnosed with ovarian cancer in 2007, according to court papers. (Balsamo, 8/21)

Source: The Associated Press

USA Today: Mylan $465M EpiPen Settlement Finalized Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that fueled nationwide debate over soaring drug costs, the agreement ends an investigation that found Mylan avoided paying state Medicaid programs higher EpiPen rebates by improperly classifying the brand name drug as a generic medication. (McCoy, 8/17)

Source: USA Today

The Associated Press: UnitedHealth CEO To Step Down After Run Of More Than Decade UnitedHealth Group has picked company President David Wichmann to replace CEO Stephen Hemsley in a long-planned transition that Wall Street greeted with polite applause.The nation’s largest health insurer says Wichmann, 54, will take over Sept. 1, and Hemsley will become executive chairman of the company’s board. Current Chairman Richard Burke will shift to lead independent director. (Murphy, 8/17)

Source: The Associated Press

USA Today: Bubonic Plague In Arizona: Fleas Found Carrying Infectious Disease Fleas tested positive for the the bubonic plague in two counties in Arizona, with public health officials warning the infectious disease that claimed millions in the Middle Ages may exist in other nearby locations, too. The plague's presence in Arizona follows three confirmed human cases in New Mexico earlier this year. (Hafner, 8/16)

Source: USA Today

The New York Times: More Young People Are Dying Of Colon Cancer When researchers reported earlier this year that colorectal cancer rates were rising in adults as young as their 20s and 30s, some scientists were skeptical. The spike in figures, they suggested, might not reflect a real increase in disease incidence but earlier detection, which can be a good thing. (Rabin, 8/22)

Source: The New York Times

Kaiser Health News: Too Few Patients Follow The Adage: You Better Shop Around Despite having more financial “skin in the game” than ever, many consumers don’t make any attempt to compare prices for health care services, a newly released study found. In a survey of nearly 3,000 adults younger than 65, about half of the roughly 1,900 who said they spent money on medical care in the previous year reported that they knew in advance what their costs would be. Of those who didn’t anticipate how much they would owe before receiving care, only 13 percent said they tried to predict their out-of-pocket expenses. (Andrews, 8/18)

Source: Kaiser Health News

California Healthline: Anthem’s Exit Leaves Thousands With No Choice Of Health Plans For about 60,000 Covered California customers, choosing a health plan next year will be easier, and possibly more painful, than ever: There will be only one insurer left in their communities after Anthem Blue Cross of California pulls out of much of the state’s individual market. That means they could lose doctors they trust, or pay higher premiums. (Ibarra, 8/18)

Source: California Healthline

The New York Times: In Tennessee, Promoting Enrollment In Tenuous Health Care Plans Sharon Barker isn’t used to recruiting new health insurance customers in deepest summer, long before the enrollment season for the Affordable Care Act. But this year, everything is different. Despite surviving Republican efforts to repeal it, the law known as Obamacare remains vulnerable. President Trump has repeatedly threatened to end billions of dollars in payments to insurance companies, but his administration decided this week to continue them for another month. (Goodnough, 8/20)

Source: The New York Times

__________________________________________________________________

The James Group, LLC is now posting current health insurance industry news article links on our Facebook page.  We will keep it simple with one to three articles per week.  Type in: The James Group, LLC in your Facebook search box to go to our page.  Please remember to like our page if you find the articles interesting. 

 

Facebook

 

Connect

Icon FacebookIcon TwitterIcon Mail

Location

Memphis Office
The James Group, LLC
6750 Poplar Avenue
Suite 208
Memphis, TN 38138
Phone: (901) 273-8600
Fax: (901) 273-8700
Atlanta Office
The James Group, LLC 
1100 Circle 75 Parkway SE, Suite 1500
Atlanta, GA 30339
Phone: 770-709-7210
Fax: 901-273-8700
Logo Footer © The James Group. All Rights Reserved.